Back to Market Feed

Product Information

NICARDIPINE 30 MG CAPSULE is a generic product labeled by Amneal Pharmaceuticals NY LLC, priced at $3.9440 per EA under NDC 69238269201. Its NADAC has been published 76 times since Feb 5, 2025.

FDA first approved this application on Apr 10, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

NICARDIPINE 30 MG CAPSULE

Nicardipine
$3.9440per EA

Strength

30 mg/1

NDC

69238269201

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

7/23/2025

Active Ingredients

NICARDIPINE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA218202

FDA Approved

4/10/2024

TE Code

AB

On Market Since

10/3/2024

Pharmacological Classes

Calcium Channel Antagonists
Cytochrome P450 2C19 Inhibitors
Cytochrome P450 2C8 Inhibitors
Cytochrome P450 2D6 Inhibitors
Cytochrome P450 3A4 Inhibitors
Dihydropyridine Calcium Channel Blocker
Dihydropyridines

Price Statistics

The NADAC for NICARDIPINE 30 MG CAPSULE has been published 76 times since Feb 5, 2025, and over the history we have for it it has risen 19.5%. The table below summarizes its recorded NADAC range and movement.

Current price$3.9440 per EA
All-time high$3.9440 (Jul 15, 2026)
All-time low$3.3006 (Feb 5, 2025)
52-week high$3.9440
52-week low$3.9440
Median price$3.9440
Average price$3.8520
Largest weekly change+6.0% (Apr 23, 2025)
Weeks tracked76
Tracking sinceFeb 5, 2025

Price History

1W

N/A

1M

N/A

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

N/A

5Y

N/A

All

+19.5%

Last surveyed Jul 15, 2026 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Nicardipine market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

AMLODIPINE BESYLATE 5 MG TAB
Generic
00480716710•Teva Pharmaceuticals USA Inc.
$0.0101
per EA
AMLODIPINE BESYLATE 5 MG TAB
Generic
00904637061•Major Pharmaceuticals
$0.0101
per EA
AMLODIPINE BESYLATE 5 MG TAB
Generic
29300039705•Unichem Pharmaceuticals (USA) Inc.
$0.0101
per EA
AMLODIPINE BESYLATE 5 MG TAB
Generic
29300039710•Unichem Pharmaceuticals (USA) Inc.
$0.0101
per EA
AMLODIPINE BESYLATE 5 MG TAB
Generic
29300039719•Unichem Pharmaceuticals (USA) Inc.
$0.0101
per EA
AMLODIPINE BESYLATE 5 MG TAB
Generic
42806005605•Epic Pharma LLC
$0.0101
per EA
AMLODIPINE BESYLATE 5 MG TAB
Generic
42806005609•Epic Pharma LLC
$0.0101
per EA
AMLODIPINE BESYLATE 5 MG TAB
Generic
42806005610•Epic Pharma LLC
$0.0101
per EA
AMLODIPINE BESYLATE 5 MG TAB
Generic
59762201001•Mylan Pharmaceuticals Inc.
$0.0101
per EA
AMLODIPINE BESYLATE 5 MG TAB
Generic
59762201003•Mylan Pharmaceuticals Inc.
$0.0101
per EA

Frequently asked questions

What is the NADAC price of NICARDIPINE 30 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for NICARDIPINE 30 MG CAPSULE, manufactured by Amneal Pharmaceuticals NY LLC, is $3.9440 per EA (NDC 69238269201), effective Jul 15, 2026.

How has the price of NICARDIPINE 30 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for NICARDIPINE 30 MG CAPSULE has risen 19.5%. It has been tracked across 76 weekly CMS publications since Feb 5, 2025.

What are the highest and lowest recorded NADAC prices for NICARDIPINE 30 MG CAPSULE?

Since Feb 5, 2025, the NADAC for NICARDIPINE 30 MG CAPSULE has ranged from a low of $3.3006 (Feb 5, 2025) to a high of $3.9440 (Jul 15, 2026), with a median of $3.9440 per EA.

Are there cheaper alternatives to NICARDIPINE 30 MG CAPSULE?

No other NADAC-published product currently shares the active ingredient and strength of NICARDIPINE 30 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures NICARDIPINE 30 MG CAPSULE?

NICARDIPINE 30 MG CAPSULE (NDC 69238269201) is labeled by Amneal Pharmaceuticals NY LLC, and CMS classifies it as a generic product.